| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.962 | 26 | 0 | 2010 | 2019 | ||||||||
|
GATA binding protein 1 | 0.483 | 0.808 | 0.95 |
|
group | 0.400 | None | 1.000 | 16 | 1 | 1999 | 2020 | ||||||||
|
CCAAT enhancer binding protein alpha | 0.496 | 0.692 | 0.55 |
|
group | 0.400 | None | 0.923 | 12 | 0 | 2002 | 2020 | ||||||||
|
colony stimulating factor 3 receptor | 0.550 | 0.692 | 1.5E-10 |
|
group | 0.400 | None | 1.000 | 12 | 0 | 1998 | 2019 | ||||||||
|
colony stimulating factor 1 receptor | 0.448 | 0.808 | 0.13 |
|
group | 0.400 | None | 1.000 | 11 | 0 | 1990 | 2009 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
group | 0.400 | None | 1.000 | 10 | 0 | 2009 | 2016 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
group | 0.380 | None | 0.875 | 8 | 2 | 2003 | 2016 | ||||||||
|
phospholipase C beta 1 | 0.595 | 0.654 | 0.98 |
|
group | 0.380 | None | 0.875 | 7 | 0 | 2004 | 2018 | ||||||||
|
BMI1 proto-oncogene, polycomb ring finger | 0.448 | 0.808 | 0.94 |
|
group | 0.370 | None | 1.000 | 7 | 0 | 2007 | 2014 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.370 | None | 1.000 | 7 | 0 | 1992 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.370 | None | 1.000 | 7 | 0 | 1988 | 2017 | ||||||||
|
delta like non-canonical Notch ligand 1 | 0.527 | 0.692 | 3.5E-02 |
|
group | 0.370 | None | 1.000 | 6 | 0 | 2001 | 2018 | ||||||||
|
sterile alpha motif domain containing 9 | 0.606 | 0.808 | 1.1E-33 |
|
group | 0.360 | None | 1.000 | 6 | 0 | 2016 | 2019 | ||||||||
|
death associated protein kinase 1 | 0.472 | 0.808 | 1.00 |
|
group | 0.350 | None | 1.000 | 5 | 0 | 2010 | 2015 | ||||||||
|
Rho GTPase activating protein 26 | 0.656 | 0.500 | 1.00 |
|
group | 0.330 | None | 0.667 | 3 | 0 | 2006 | 2011 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
group | 0.330 | None | 1.000 | 3 | 0 | 2010 | 2017 | ||||||||
|
catenin alpha 1 | 0.584 | 0.538 | 0.97 |
|
group | 0.330 | None | 1.000 | 3 | 0 | 2007 | 2014 | ||||||||
|
cut like homeobox 1 | 0.465 | 0.846 | 1.00 |
|
group | 0.330 | None | 1.000 | 3 | 0 | 2015 | 2019 | ||||||||
|
CASP8 and FADD like apoptosis regulator | 0.485 | 0.846 | 1.00 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2003 | 2007 | ||||||||
|
stromal antigen 2 | 0.568 | 0.731 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2017 | ||||||||
|
acyl-CoA synthetase long chain family member 6 | 0.686 | 0.500 | 3.2E-03 |
|
group | 0.310 | limited | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
LYL1 basic helix-loop-helix family member | 0.670 | 0.192 | 0.77 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
CST telomere replication complex component 1 | 0.601 | 0.538 | 1.6E-11 |
|
group | 0.310 | strong | 1.000 | 1 | 0 | 2017 | 2019 | ||||||||
|
histone deacetylase 1 | 0.460 | 0.846 | 0.61 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
group | 0.200 | None | 0.969 | 30 | 1 | 2005 | 2020 |